國立高雄大學圖資館 |

Language: English

Back

Metabolic dysfunction-associated steatotic liver diseaseprevalence, research insights and the future directions /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Metabolic dysfunction-associated steatotic liver diseaseedited by Nahum Méndez-Sánchez, Xingshun Qi.
Reminder of title:	prevalence, research insights and the future directions /
other author:	Méndez-Sánchez, Nahum.
Published:	Singapore :Springer Nature Singapore :2024.
Description:	viii, 170 p. :ill. (chiefly color), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Fatty liverPathophysiology.
Online resource:	https://doi.org/10.1007/978-981-97-9519-2
ISBN:	9789819795192$q(electronic bk.)

Metabolic dysfunction-associated steatotic liver diseaseprevalence, research insights and the future directions /
Metabolic dysfunction-associated steatotic liver diseaseprevalence, research insights and the future directions /[electronic resource] :edited by Nahum Méndez-Sánchez, Xingshun Qi. - Singapore :Springer Nature Singapore :2024. - viii, 170 p. :ill. (chiefly color), digital ;24 cm.

Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD's pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.

This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.

ISBN: 9789819795192$q(electronic bk.)

Standard No.: 10.1007/978-981-97-9519-2doiSubjects--Topical Terms:

987148
Fatty liver
--Pathophysiology.

LC Class. No.: RC848.F3

Dewey Class. No.: 616.362

Metabolic dysfunction-associated steatotic liver diseaseprevalence, research insights and the future directions /
LDR:02613nmm a2200325 a 4500 001 673603
003 DE-He213
005 20241231115242.0
006 m d
007 cr nn 008maaau
008 250422s2024 si s 0 eng d
020 $a 9789819795192$q(electronic bk.)
020 $a 9789819795185$q(paper)
024 7 $a 10.1007/978-981-97-9519-2 $2 doi
035 $a 978-981-97-9519-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.F3
072 7 $a MNG $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MNG $2 thema
082 0 4 $a 616.362 $2 23
090 $a RC848.F3 $b M587 2024
245 0 0 $a Metabolic dysfunction-associated steatotic liver disease $h [electronic resource] : $b prevalence, research insights and the future directions / $c edited by Nahum Méndez-Sánchez, Xingshun Qi.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a viii, 170 p. : $b ill. (chiefly color), digital ; $c 24 cm.
505 0 $a Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD's pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.
520 $a This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.
650 0 $a Fatty liver $x Pathophysiology. $3 987148
650 0 $a Fatty liver $x Treatment. $3 987149
650 1 4 $a Gastroenterology. $3 274091
700 1 $a Méndez-Sánchez, Nahum. $3 987147
700 1 $a Qi, Xingshun. $3 861814
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-9519-2
950 $a Medicine (SpringerNature-11650)